companydata.dkcompanydata.dk

PharmaMénta Aps: Financial statements 2018

CVR: 25615697

Source: annual report 2018, Danish Business Authority

01/01/201831/12/2018

PharmaMénta Aps (CVR 25615697) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -5,366 and a net result of DKK -8,422 compared with DKK -5,137,618 the year before. Equity in the 2018 report amounted to DKK 467,209. The solvency ratio was 97.9%.

Gross Profit
DKK -5,366
Profit/Loss
DKK -8,422
Equity
DKK 467,209
Total Assets
DKK 477,213

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2018--5 t.-8 t.467 t.-
2017-1.1 mio.-5.1 mio.476 t.-
2016-1.3 mio.1.1 mio.5.6 mio.-
2015-126 t.204 t.4.5 mio.-
2014--2 t.125 t.4.3 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2018

PharmaMénta Aps: The 2017 annual report is outJun 1, 2018

PharmaMénta Aps has published its annual report for 2017. Gross profit came to DKK 1,119,779, and the net result was DKK -5,137,618.

About PharmaMénta Aps

PharmaMénta Aps is a Danish company of the type Anpartsselskab based in Esbjerg V, founded in 2000. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jimmi Javed Christensen Malik. The board consists of Lasse Hvingelby Kikkenborg (chair), Jimmi Javed Christensen Malik and Torben Hvingelby Pedersen. The company is owned by Torben Hvingelby Pedersen, LHK Holding Esbjerg ApS and JMINT Holding ApS. The company has 3 employees (2008). In 2025, the company reported a gross profit of DKK 5,249,012 and a net result of DKK 2,364,968 compared with DKK 2,121,363 the year before. Equity in the 2025 report amounted to DKK 5,130,022.

Source: annual report 2025, Danish Business Authority